True Wealth Design’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
HWAM
BC
GI
FFA
VCM
TFA
True Wealth Design's RIGL Position: Q2 2026 in Review
True Wealth Design held its Rigel Pharmaceuticals (RIGL) position steady in Q2 2026 at 28 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.
True Wealth Design first reported a position in RIGL in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.24K in Q4 2025. 7 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.
- True Wealth Design held 28 shares of Rigel Pharmaceuticals worth $1.1K as of Q2 2026.
- True Wealth Design left its Rigel Pharmaceuticals share count unchanged in Q2 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1945 holding.
- True Wealth Design first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- True Wealth Design's Rigel Pharmaceuticals position peaked at $1.24K in Q4 2025.
- 7 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.
Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.